GUIDELINES FOR THE PREVENTION, DETECTION AND THERAPY OF VITAMIN D DEFICIENCY IN ADULTS.

It is estimated that over one billion of people around the globe have low serum values of vitamin D, therefore, we can consider vitamin D deficiency as a pandemic and public health problem. Geographic position of Croatia, especially the continental part of the country, is a risk factor for the development of deficiency of vitamin D in the population. The aim of these guidelines is to provide the clinicians with easy and comprehensive tool for prevention, detection and therapy of vitamin D deficienney in healthy population and various groups of patients. They were made as a result of collaboration of clinicians of different backgrounds who are dealing with patients at risk of vitamin D deficiency. These guidelines are evi- dence-based, according to GRADE-system (Grading of Recommendations, Assessment, Development and Evaluation), which describes the level of evidence and strength of recommendation. The main conclusions address the recommended serum vitamin D values in the population which should be between 75 and 125 nmol/L and defining recommended preven- tive and therapeutic dosages of vitamin D in order to reach the adequate levels of serum vitamin D.

[1]  N. Dabelić,et al.  Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors. , 2017, Breast.

[2]  A. Sahebkar,et al.  Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis. , 2017, Current pharmaceutical design.

[3]  David A. Jolliffe,et al.  Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  J. Damoiseaux,et al.  A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  C. Mantzoros,et al.  Hypovitaminosis D in bariatric surgery: A systematic review of observational studies. , 2016, Metabolism: clinical and experimental.

[6]  J. Damoiseaux,et al.  Illuminating vitamin D effects on B cells – the multiple sclerosis perspective , 2016, Immunology.

[7]  Weiqian Chen,et al.  Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis , 2016, PloS one.

[8]  D. Harvey,et al.  Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. , 2015, JAMA neurology.

[9]  A. Szymczak,et al.  The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases , 2015, Archives of medical science : AMS.

[10]  Junxia Yang,et al.  Effect of vitamin D on the recurrence rate of rheumatoid arthritis , 2015, Experimental and therapeutic medicine.

[11]  A. Ponsonby,et al.  Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings , 2015, PloS one.

[12]  W. Lems,et al.  Bisphosphonates and glucocorticoid-induced osteoporosis: cons , 2015, Endocrine.

[13]  C. Wolfson,et al.  Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study , 2015, Multiple sclerosis.

[14]  M. Eliades,et al.  Vitamin D: a new player in non-alcoholic fatty liver disease? , 2015, World journal of gastroenterology.

[15]  Y. Levy,et al.  Vitamin D Antibodies in Systemic Sclerosis Patients: Findings and Clinical Correlations. , 2015, The Israel Medical Association journal : IMAJ.

[16]  J. Payer,et al.  Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? , 2015, Journal of Crohn's & colitis.

[17]  M. O'Sullivan Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? , 2014, Proceedings of the Nutrition Society.

[18]  M. Aapro,et al.  Bone health in cancer patients: ESMO Clinical Practice Guidelines. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  K. Madsen,et al.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. , 2014, World journal of gastroenterology.

[20]  Amal M. H. Mackawy,et al.  Vitamin d deficiency and its association with thyroid disease. , 2013, International journal of health sciences.

[21]  S. Patten,et al.  The case for vitamin D supplementation in multiple sclerosis. , 2013, Multiple sclerosis and related disorders.

[22]  Zeng-li Zhang,et al.  Vitamin D Intake and Risk of Type 1 Diabetes: A Meta-Analysis of Observational Studies , 2013, Nutrients.

[23]  K. Robien,et al.  Drug-vitamin D interactions: a systematic review of the literature. , 2013, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[24]  C. Stokes,et al.  Vitamin D in chronic liver disease , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[25]  H. Bischoff-Ferrari Relevance of vitamin D in bone and muscle health of cancer patients. , 2012, Anti-cancer agents in medicinal chemistry.

[26]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[27]  M. Cantorna Vitamin D, multiple sclerosis and inflammatory bowel disease. , 2012, Archives of biochemistry and biophysics.

[28]  Lynette M. Smith,et al.  Dose Response to Vitamin D Supplementation in Postmenopausal Women , 2012, Annals of Internal Medicine.

[29]  M. Melamed,et al.  Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. , 2011, The Journal of clinical endocrinology and metabolism.

[30]  M. Holick,et al.  Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. , 2011, The Journal of clinical endocrinology and metabolism.

[31]  Ž. Crnčević-Orlić,et al.  VITAMIN D: VITAMIN PROŠLOSTI, HORMON BUDUĆNOSTI , 2011 .

[32]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[33]  Y. Shoenfeld,et al.  Vitamin D and autoimmune thyroid diseases , 2011, Cellular and Molecular Immunology.

[34]  J. Manson,et al.  Vitamin D and prevention of cancer--ready for prime time? , 2011, The New England journal of medicine.

[35]  S. Pilz,et al.  Role of vitamin D in arterial hypertension , 2010, Expert review of cardiovascular therapy.

[36]  J. Simpson,et al.  Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.

[37]  Y. Shoenfeld,et al.  Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? , 2010, Annals of the rheumatic diseases.

[38]  O. Polašek,et al.  Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis , 2010, Clinical Rheumatology.

[39]  J. Adachi,et al.  Glucocorticoid-induced osteoporosis: treatment update and review , 2009, Therapeutic advances in musculoskeletal disease.

[40]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[41]  P. Menheere,et al.  The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. , 2009, Autoimmunity reviews.

[42]  M. Holick The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. , 2008, Molecular aspects of medicine.

[43]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[44]  S. Ish-shalom,et al.  Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. , 2008, The Journal of clinical endocrinology and metabolism.

[45]  B. Nakken,et al.  The Complex Role of Vitamin D in Autoimmune Diseases , 2008, Scandinavian journal of immunology.

[46]  L. Adorini,et al.  Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.

[47]  J. Bilezikian,et al.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.

[48]  C. Gordon,et al.  Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease , 2006, Inflammatory bowel diseases.

[49]  M. Holick Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[50]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[51]  C. Cooper,et al.  A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. , 2005, QJM : monthly journal of the Association of Physicians.

[52]  L. Mosekilde Vitamin D and the elderly , 2005, Clinical endocrinology.

[53]  H. Stähelin,et al.  A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min , 2005, Osteoporosis International.

[54]  Yan Zhu,et al.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.

[55]  C. Polman,et al.  Multiple sclerosis and vitamin D: an update , 2004, European Journal of Clinical Nutrition.

[56]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[57]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[58]  H. Glerup,et al.  Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.

[59]  M. Holick,et al.  AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.

[60]  P. Goldberg,et al.  Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. , 1986, Medical hypotheses.

[61]  C. Christiansen,et al.  Regulation of vitamin D and calcium metabolism after gastrectomy. , 1985, Gut.

[62]  M. Lilburn,et al.  25-Hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia. , 1977, British medical journal.

[63]  R. L. Eddy Metabolic bone disease after gastrectomy. , 1971, The American journal of medicine.

[64]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.

[65]  Karen S Henry,et al.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline , 2015 .

[66]  L. Fonseca,et al.  Vitamin D: non-skeletal actions and rational use. , 2013 .

[67]  G. Rebecca,et al.  American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 2011 .

[68]  Christine L. Taylor,et al.  Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .

[69]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[70]  K. Helzlsouer American Journal of Epidemiology Original Contribution Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2022 .